As of 2025-05-12, the Relative Valuation of THC Biomed Intl Ltd (THC.CN) is (0.20) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of THC Biomed Intl Ltd based on Relative Valuation is -1079.8%.
The range of the Relative Valuation is (0.13) - (0.25) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.6x - 5.7x | 4.2x |
| Forward P/E multiples | 2.8x - 6.4x | 4.6x |
| Fair Price | (0.13) - (0.25) | (0.20) |
| Upside | -727.1% - -1372.0% | -1079.8% |
| Date | P/E |